Case ReportIndian Journal of Pharmaceutical Education and ResearchVol. 52 | Issue 3 | 2018 | pp. 540–542Open access
Immune Thrombocytopenia (ITP) in a Patient with Relapsing-Remitting Multiple Sclerosis (RRMS) Associated with b-Interferon-1α Treatment
- 1,2,
- 1,3,
- 1,3,
- 1,4*
- 1 Isfahan Neuroscience Research Center, Isfahan University of Medical Sciences, Isfahan, IRAN.
- 2 Department of Neurology, Isfahan University of Medical Sciences, Isfahan, IRAN.
- 3 Medical students’ research Committee, Isfahan University of Medical Sciences, Isfahan, IRAN.
- 4 Non-communicable Disease Unit, Vice Chancellor for Clinical Affairs, Isfahan University of Medical Sciences, Isfahan, IRAN.
Published in Indian Journal of Pharmaceutical Education and Research
Correspondence: Nafiseh Toghianifar
Isfahan Neuroscience Research Center, Isfahan University of Medical Sciences, Isfahan, IRAN.; Non-communicable Disease Unit, Vice Chancellor for Clinical Affairs, Isfahan University of Medical Sciences, Isfahan, IRAN.
Email: n.toghiani@gmail.com
Copyright: © 2018 Manuscript Technomedia. This is an open access article.
- Published:
- Jun 17, 2018
- Received:
- Sep 29, 2017
- Accepted:
- Dec 15, 2017
How to cite
Shaygannejad, V., Fayyazi, E., Mirmosayyeb, O., & Toghianifar, N. (2018). Immune Thrombocytopenia (ITP) in a Patient with Relapsing-Remitting Multiple Sclerosis (RRMS) Associated with b-Interferon-1α Treatment. Indian Journal of Pharmaceutical Education and Research, 52(3), 540–542. https://doi.org/10.5530/ijper.52.3.62
Abstract
Immune thrombocytopenia is an isolated thrombocytopenia not related to other etiologies of thrombocytopenia.1 The diagnosis relies mainly on exclusion of other conditions.2,3 The incidence of ITP among adults has been estimated to be 3.3 per 100,000 persons in Europe according to a review study in 2009.4 ITP may be induced by drugs.2 In this type of ITP, a drug induces production of antibodies against platelets and causes destruction and reduction of platelets.2 This is usually transient and improves after withdrawal of the offending drug.1,2
Subject
Article metadata
| Title | Immune Thrombocytopenia (ITP) in a Patient with Relapsing-Remitting Multiple Sclerosis (RRMS) Associated with b-Interferon-1α Treatment |
|---|---|
| Authors | Vahid Shaygannejad; Emad Fayyazi; Omid Mirmosayyeb; Nafiseh Toghianifar |
| Affiliations | Isfahan Neuroscience Research Center, Isfahan University of Medical Sciences, Isfahan, IRAN.; Department of Neurology, Isfahan University of Medical Sciences, Isfahan, IRAN.; Medical students’ research Committee, Isfahan University of Medical Sciences, Isfahan, IRAN.; Non-communicable Disease Unit, Vice Chancellor for Clinical Affairs, Isfahan University of Medical Sciences, Isfahan, IRAN. |
| Corresponding author | n.toghiani@gmail.com |
| Journal | Indian Journal of Pharmaceutical Education and Research |
| Volume / Issue | Vol. 52, Issue 3 (2018) |
Also in this issue
- Development of pH Independent Drug Release System for Dipyridamolepp. 374–380
- Enantioseparation of D- and L- isomers of Chiral Drugs for Improving their Bioavailability: Some Techniques Including Micellization with Gemini Surfactantspp. 334–341
- “Breaking Bad” Television Series Explained to Studentspp. 342–350
- Service Quality Gap Measurement in Pharmaceutical Educational Institutes: An Empirical Analysis for Model Developmentpp. 351–362
- Carboxymethyl Tamarind Seed Kernel Polysaccharide Formulated into Pellets to Target at Colonpp. 363–373
Readers Also Viewed
Effect of the Fractions of Coccinia grandis on Ethanol- Induced Cerebral Oxidative Stress in Rats
M. Umamaheswari, T. K. Chatterjee
Jan 1, 2009
Phytochemical Screening and Antioxidant Activity Evaluation of Selected Philippine Fruit Peels and Pulps
Mildred Dagcuta Pates, Angelo Mark Po Walag, Romeo M. Del Rosario
Aug 17, 2026
Impact of Artificial Intelligence Assisted Drug Therapy Optimization on Drug Related Problems Amongst Older Adult Patients: A Systematic Review
Jehath Syed, Christy Thomas, Bavneet Kaur
Oct 23, 2026